Comparison

TreatHF vs Cardiotox

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

TreatHF

This clinical decision support tool offers personalized heart failure therapy recommendations for healthcare professionals. It guides clinicians on medication initiation, titration, and optimization based on patient indications, referencing the latest guidelines.

Highlights
  • Individualized therapy suggestions
  • Guidance on medication use
  • Patient indication entry
  • Next steps for medical therapy
  • Medication initiation and titration
  • Optimization of medication strategy
Features
Read full description

TreatHF is a clinical decision support app that provides clinicians individualized therapy suggestions for their symptomatic heart failure patients and provides guidance on the use of each therapy. • Enter patient indications • Review individualized next steps for medical therapy • Email or print a summary of the next steps • Reference detailed information for - Initiation, titration, and monitoring of each medication - Guidance for optimizing your overall medication strategy. Content in this app is derived from the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure, the 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction, and the 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure With Reduced Ejection Fraction. The information and recommendations in this clinical decision support app are not meant to represent the only or best course of care nor replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.

About

Cardiotox

Features
Read full description

Cardiotox® : The drug-induced/iatrogenic cardiotoxicity website & App The companion website and App Pneumotox ® addresses drug- and chemical-induced/iatrogenic pneumotoxicity. By Philippe Camus MD Professor (emeritus) (board-certified pulmonary medicine, cardiology) - Université Bourgone-Europe, Dijon, France. Cardiotox is an aid to the diagnosis and management of cardiotoxicity and cardiac reactions suspected of being induced by drugs, herbals, chemicals, radiation therapy and/or of iatrogenic origin.. Causality assessment and exact diagnosis are the full responsibility of the user. Cardiotox is designed to provide regularly-updated information on drugs causing cardiac toxicity (> 530), resulting patterns of involvement (> 400) and bibliography (3,950 references as of August 2026) within a few minutes. That may be the real crux in emergency situations, and enabling prompt withdrawal. Yet, double-checking in and from other sources is indicated. Cardiotox rests on a bibliographic repository of drug-induced pneumo- and cardiotoxicity built since 1978, that amounts to > 50,000 references as of August, 2026. The vast majority of these is indexed in PubMed. All references were and are still being carefully reviewed for reliability and causality by the founder, then indexed under the umbrella of the corresponding drug or agent. One can access Cardiotox by both causative drugs, chemicals, herbals, substances of abuse, inhalants, gases, radiation therapy and/or patterns of involvement. Drug names are generic (International Nonproprietary Names (INN), alphabetical), not brand. It may be appropriate to check the exact composition of any proprietary drug, as any other added substance or excipient can be toxic.Matching generic and brand names is country - dependent. Patterns are grouped by families according to the main anatomic site of involvement. If a drug or drug reaction is listed in Cardiotox, this does not equate the patient is demonstrating actual toxicity. A “Diagnosing DICD” window in Cardiotox can help fortify the diagnosis. Lack of case in the literature or in Cardiotox does not exclude a diagnosis of drug cardiotoxicity as there may be unpublished cases, you may be seeing the first case ever, or we may have overlooked some information. In such situations, Cardiotox or Pneumotox cannot be held responsible. At any rate, the founder of Cardiotox can be contacted by mail 7/7. A search for exposure to drugs, substances of abuse, and/or chemicals must be done exhaustively with the patient, family, health professionals, pharmacy and/or law enforcement personel. This can be life-saving, enabling appropriate drug withdrawal. Caution: Drug therapy withdrawal can cause flare of the background disease. Deliberate rechallenge of patient with the drug can be hazardous and lead to fatal consequences. Early sampling of body fluids for drugs and/or metabolites is indicated as early as possible, particularly in the severely ill. Knowledge of toxidromes and antidotes to combat them is also precious. Where in doubt, consider double-checking PubMed, your affiliated Safety for Medicines Department/Agency and the Pharmacovigilance Department of drug companies. They may host more and/or undisclosed information. Patients should be reassured as such incidents are rare. If needed, they are invited to consult with their treating physicians or via Cardiotox. You may contact Cardiotox through the contact window. ALL RIGHTS RESERVED The current version of Cardiotox website and App were developed by Akyos Communication, Dijon, France Pneumotox received a generous Grant from the ERS in 2019

Screenshots

TreatHF4 screens
Cardiotox4 screens

Verdict

The call

The clearest difference is update cadence: TreatHF at every 7 months against Cardiotox's every 35 months. TreatHF also leads on iOS requirement (13.0 vs 16.4). On price, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

TreatHF ships an update every 7 months, Cardiotox every 35 months. The most recent releases landed on November 20, 2026 and November 19, 2026 respectively.

Scorecard2 real differences · 7 level
TreatHF versus Cardiotox: the parameters behind the verdict, then further details
ParameterTreatHFCardiotox
PriceFreeFree
Rating5.0 (5 ratings) — better—
Number of ratings5 — better—
Update frequencyEvery 7 months — betterEvery 35 months
AdsNoNo
In-app purchasesNoNo
MonetizationFree—
DevicesiPhone, iPad, iPod — betteriPhone, iPad
Requires iOS13.0 — better16.4
Further details — not scored
Size13 MB54 MB
Age rating17+17+
DeveloperAmerican College of CardiologyPhilippe Camus

In-app purchases

None

TreatHF

No in-app purchases

None

Cardiotox

No in-app purchases

Questions

Is TreatHF free?
TreatHF is free to download, with no in-app purchases.
Is Cardiotox free?
Cardiotox is free to download, with no in-app purchases.
Do TreatHF or Cardiotox have ads?
Neither TreatHF nor Cardiotox shows ads.
Which is updated more often, TreatHF or Cardiotox?
TreatHF ships an update every 7 months, and Cardiotox every 35 months. Most recently, TreatHF was updated on November 20, 2026 and Cardiotox on November 19, 2026.

Other comparisons